학술논문
Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
Document Type
Article
Author
Source
In The Lancet HIV July 2023 10(7):e433-e441
Subject
Language
ISSN
2352-3018